Cytokine patterns using molecular tools

Indian Journal of Leprosy

Volumn 72, Issue 2, 2000, Pages 175-185

  Vemuri, N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEPROSTATIC AGENT; LYMPHOTOXIN; MESSENGER RNA; RECOMBINANT CYTOKINE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 2; THALIDOMIDE; TUMOR NECROSIS FACTOR;

ANTIBODY PRODUCTION; CLINICAL TRIAL; CONFERENCE PAPER; CYTOKINE RELEASE; DIAGNOSTIC VALUE; DISEASE COURSE; ENZYME INHIBITION; ERYTHEMA NODOSUM LEPROSUM; FUNCTIONAL ASSESSMENT; GENE EXPRESSION REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; LEPROMATOUS LEPROSY; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH2 CELL; TUBERCULOID LEPROSY;

CYTOKINES; HUMANS; IMMUNOASSAY; LEPROSY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH1 CELLS; TH2 CELLS;

EID: 0033826831     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. Tumor necrosis factor production in patients with leprosy
2. Patterns of cytokine production by Mycobacterium-reactive human T-cell clones
3. Recombinant cytokines for controlling mycobacterial infections
4. + T-cells from blood and skin lesions of leprosy patients. Identification of T-cell clones distinct from Th0, Th1 and Th2
5. + T-cells: Specificity and function
6. An analysis of in-vitro T-cell unresponsiveness in lepromatous leprosy
7. Cellular responses to the intradermal injection of recombinant human interferon-γ in lepromatous leprosy patients
8. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin-2
9. Effect of multiple interferon-γ injections on the disposal of Mycobacterium leprae
10. Tumour necrosis factor-alpha (TNF-α) synthesis associated with the skin and peripheral nerve pathology of leprosy reversal reactions
11. Natural emergence of antigen reactive T-cells in lepromatous leprosy patients during erythema nodosum leprosum
12. Interferon-γ differentially regulates interleukin-12 and interleukin-10 production in leprosy
13. Cytokine profile of circulating T-cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae
14. In-situ and in-vitro characterization of the cellular immune response in erythema nodosum leprosum
15. Defective cell mediated immunity in leprosy and failure of T-cells from lepromatous leprosy patients to respond to M. leprae is associated with defective expression of interleukin-2 receptors and is not reconstituted by interleukin-2
16. Two types of murine helper T-cell clones
17. Analysis of cytokine production by Mycobacterium-reactive T-cells
18. Differences in predominant T-cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy
19. Inhibition of interleukin-2 production by adherent factors from lepromatous leprosy patients
20. The role of cytokines in leprosy
21. Local and systemic effects of low doses of recombinant interferon-γ after intradermal injection in patients with lepromatous leprosy
22. Widespread intradermal accumulation of mononuclear leukocytes in lepromatous leprosy patients treated systemically with recombinant interferon-γ
23. Defective IFN-γ production in leprosy. Reversal with antigen and interleukin-2
24. Cloned suppressor T-cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T-cell
25. Serum tumour necrosis factor and interleukin-1 in leprosy and during lepra reactions
26. Lymphokine production by human T-cells in disease states
27. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T-cells clones
28. Expression and cytokine secretion in the states of immune reactivation in leprosy
29. Thalidomide selectively inhibits TNF-α production by stimulated human monocytes
30. Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy
31. Effect of rhuIFN-γ treatment in multibacillary leprosy patients
32. A study of the effects of intradermal administration of recombinant gamma interferon in lepromatous leprosy patients
33. + T-cells
34. Soluble interleukin-2 receptors: Levels in leprosy during and after type 1 (lepra) and type 2 (ENL) reactions
35. Effect of recombinant interferon gamma administration on lesional monocytes/macrophages in lepromatous leprosy patients
36. Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions
37. IL-4 directs the synthesis of Th2-like helper effectors
38. Cell changes and soluble interleukin-2 receptors (Tac peptide) in leprosy reversal reactions using suction-induced blisters
39. Interleukin-12: A proinflammatory cytokine with immunomodulatory functions that bridge innate resistance and antigen-specific adaptive immunity
40. Serum soluble interleukin-2 receptor levels in leprosy patients
41. Type 1- and Type 2-like lesional skin-derived Mycobacterium leprae-responsive T-cell clones are characterized by co-expression of IFN-gamma, TNF-alpha and IL-4-5/IL-13 respectively
42. Defining protective responses to pathogens: Cytokine profiles in leprosy lesions
43. Cytokine patterns of immunologically mediated tissue damage
44. IL-10 and human T-cells